Trial to assess the effect of blood pressure lowering drug (Dexmedetomidine) to control blood loss during spine surgery
Phase 3
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/05/042376
- Lead Sponsor
- OT APPLICABLE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients giving consent
Elective spinal surgeries only
Patients aged >18 years & < 65 years
Patients of either sex
ASA Grade I & II
Exclusion Criteria
PREGNANT PATIENTS
PATIENTS SUFFERING FROM HYPERTENSION
UNCONTROLLED DIABETES MELLITUS
MORBID OBESITY
COPD
SEVERE RENAL, HEPATIC, CARDIAC DYSFUNCTION
EMERGENCY SPINE SURGERY
HISTORY OF DRUG ABUSE
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HYPOTENSION <br/ ><br>BLOOD LOSS <br/ ><br>ANALGESIA USETimepoint: HYPOTENSION - EVERY 30 MINUTES <br/ ><br>BLOOD LOSS - EVERY 30 MINUTES <br/ ><br>ANALGESIA USE - EVERY 30 MINUTES
- Secondary Outcome Measures
Name Time Method ANALGESIA REQUIREMENTTimepoint: ANALGESIA USE - EVERY 1 HOUR